Sleep changes with age: it becomes lighter, more fragmented, and harder to start. Poor sleep and declining memory often travel together in later life, which is why researchers keep looking for gentle, low-risk ways to support sleep without adding medications. In 2026, several trials tested one of the simplest candidates — inhaling essential oils at set times of day — in older adults. Here is what they actually found, and what they do not yet show.
How to read the evidence levels on The Oil Owl: A = human clinical data, B = animal (in vivo) studies, C = cell or test-tube (in vitro) studies, D = theoretical.
Trial 1: Morning and Evening Blends in a Care Home — Evidence Level A (small RCT)
A single-blind randomized controlled trial in a residential care facility in Istanbul enrolled 60 adults aged 65 and over (PMID 42011111). For 30 days, the intervention group inhaled a peppermint–palmarosa blend each morning and a blend of vetiver, cedarwood, clary sage, petitgrain and grapefruit at night, ten minutes at a time. The control group received no aromatherapy.
Compared with controls, the aromatherapy group showed longer total sleep time, more REM and deep sleep, and shorter time to fall asleep, measured with wrist-worn smartwatches, plus better questionnaire scores for sleep quality and daytime sleepiness. Scores on a short orientation–memory–concentration test also improved.
How to read it: the design is thoughtful — a "circadian-aligned" protocol with an alerting morning blend and a calming evening blend, and objective as well as subjective measures. But the sample is small, the control group received nothing (so attention and ritual are not separated from the scent itself), participants knew whether they were smelling oils, and consumer smartwatches are only approximate sleep-stage trackers. The cognitive test is a screening tool, not a measure of long-term brain aging.
Trial 2: Bergamot and Clary Sage at Night — Evidence Level A (pilot RCT)
A pilot randomized trial in a Taiwanese long-term care facility compared 15 minutes of nightly inhalation of bergamot and clary sage with an unscented almond-oil control for four weeks (PMID 42033381). Thirty-seven residents completed the study. The aromatherapy group improved more on a standard sleep-quality questionnaire and on a depression screening scale. One participant stopped because of mild intolerance; there were no serious adverse events.
The unscented-oil control is a strength. The size — 19 versus 18 residents — is the main limitation, and the authors themselves call the results preliminary.
The Bigger Picture — Evidence Level A (network meta-analysis)
A 2026 network meta-analysis in Sleep Medicine Reviews pooled 18 randomized trials (1,208 participants) of non-drug interventions for sleep quality in institutionalized older adults without dementia (PMID 41880825). Aromatherapy was among the approaches associated with better sleep scores, alongside acupressure, reminiscence therapy and yoga. Network comparisons rest on few, small trials per intervention, so rankings should be read as hypotheses rather than a league table.
A Reality Check From Memory Research — Evidence Level A
Not every scent study is positive. In a 2026 experiment, young and older adults learned objects in the presence or absence of lavender scent. Overall, the odour context did not improve recognition or fine-grained memory discrimination; effects depended on timing and on each person's sense of smell, which declines with age (PMID 42866450). Smell ability itself may shape who benefits — a point most aromatherapy trials do not yet measure.
Why Might Bedtime Scent Help?
Several mechanisms are plausible, and most are still preclinical:
- Odour-triggered calm (Evidence Level B). In mice, linalool vapour reduced anxiety-like behaviour only when the animals could smell, via GABA-A receptors — see our linalool deep-dive.
- Ritual and conditioning (Evidence Level D). A consistent scent at the same time each night may act as a cue for winding down, much like dimming lights.
- Stress physiology (Evidence Level A, small). In a separate 2026 placebo-controlled study in stressed adults, two weeks of inhaling an essential-oil blend normalized a blunted cortisol awakening response during use, with no lasting effect afterwards (PMID 42262170).
A New Safety Warning: "Flavoured-Air" Inhalers
Not all inhaled products are equal. A 2026 laboratory study exposed human nasal airway cells to vapour from six commercial "flavoured-air" devices marketed as natural alternatives to vaping. Five of six flavours impaired the cells' barrier function after one hour, and chemical analysis found compounds of concern such as pulegone and cinnamaldehyde (Evidence Level C) (PMID 42587134). Deep, repeated puffing on a device is not the same as a few drops on a cotton pad or brief diffusion in a ventilated room.
What This Means in Practice
These trials do not show that aromatherapy addresses insomnia, depression or cognitive decline. They do suggest that a short, consistent, pleasant scent ritual may support subjective sleep quality in older adults — at very low risk when done sensibly.
- Short and consistent: 10–15 minutes before bed, not all-night diffusion.
- Gentle oils, low amounts: a drop or two on a tissue or a personal inhaler stick; ventilate the room.
- Mind the airways: stop if you notice coughing, headache or irritation; extra care with asthma.
- Care settings: check with staff and residents first — not everyone likes the same scent, and some people are sensitive.
- Medications and sleep problems: persistent poor sleep deserves a medical check-up; do not stop or change any sleep medication without your doctor.
- Never swallow essential oils, and keep them out of reach of people with dementia, children and pets.
Current Evidence Summary Two small 2026 randomized trials in older adults (Evidence Level A, PMID 42011111, PMID 42033381) and a network meta-analysis (A, PMID 41880825) suggest inhaled aromatherapy may support self-reported sleep quality in care settings. Trials are small, blinding is limited, and long-term or cognitive outcomes are unproven. Mechanisms are mostly preclinical (B/D). Commercial "flavoured-air" inhalers raised airway-safety concerns in vitro (C).
References
- Ede Sarıkaya B et al. J Gerontol A Biol Sci Med Sci 2026 (NCT06208800). PMID 42011111
- Wang LF et al. Clin Gerontol 2026. PMID 42033381
- Pangaribuan SM et al. Sleep Med Rev 2026. PMID 41880825
- Mannion R et al. Front Aging Neurosci 2026. PMID 42866450
- Moss M et al. Stress 2026. PMID 42262170
- Larcombe AN et al. Arch Toxicol 2026. PMID 42587134
- Harada H et al. Front Behav Neurosci 2018. PMID 30405369
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Essential oils are not a substitute for medical treatment, and they must never be swallowed. The studies discussed are small and preliminary. Always consult a qualified healthcare professional before using essential oils for health purposes, especially if you are pregnant, nursing, have a medical condition, take medications, or care for someone with dementia.